These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16288681)

  • 41. Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol.
    Tauscher J; Küfferle B; Asenbaum S; Tauscher-Wisniewski S; Kasper S
    Psychopharmacology (Berl); 2002 Jun; 162(1):42-9. PubMed ID: 12107616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clozapine can induce high dopamine D(2) receptor occupancy in vivo.
    Suhara T; Okauchi T; Sudo Y; Takano A; Kawabe K; Maeda J; Kapur S
    Psychopharmacology (Berl); 2002 Feb; 160(1):107-12. PubMed ID: 11862380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of CNS occupancy of dopamine D2 receptor based on systemic exposure and in vitro experiments.
    Kanamitsu K; Arakawa R; Sugiyama Y; Suhara T; Kusuhara H
    Drug Metab Pharmacokinet; 2016 Dec; 31(6):395-404. PubMed ID: 27745731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.
    Olsen CK; Brennum LT; Kreilgaard M
    Eur J Pharmacol; 2008 Apr; 584(2-3):318-27. PubMed ID: 18325493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride.
    Mukherjee J; Christian BT; Narayanan TK; Shi B; Mantil J
    Neuropsychopharmacology; 2001 Oct; 25(4):476-88. PubMed ID: 11557161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Theory in antipsychotic drug therapy for schizophrenia].
    Tomioka S; Ishigooka J
    Seishin Shinkeigaku Zasshi; 2006; 108(6):614-8. PubMed ID: 16910539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
    Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
    Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors.
    McCormick PN; Wilson VS; Wilson AA; Remington GJ
    Pharmacol Res; 2013 Apr; 70(1):66-71. PubMed ID: 23327779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography.
    Clark-Papasavas C; Dunn JT; Greaves S; Mogg A; Gomes R; Brownings S; Liu K; Nwosu B; Marsden P; Joemon J; Cleij M; Kessler R; Howard R; Reeves S
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1001-9. PubMed ID: 24578318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis.
    Iyo M; Tadokoro S; Kanahara N; Hashimoto T; Niitsu T; Watanabe H; Hashimoto K
    J Clin Psychopharmacol; 2013 Jun; 33(3):398-404. PubMed ID: 23609386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of new antipsychotic medications: occupancy is not just antagonism.
    Grunder G; Carlsson A; Wong DF
    Arch Gen Psychiatry; 2003 Oct; 60(10):974-7. PubMed ID: 14557141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine.
    Seeman P; Tallerico T
    Am J Psychiatry; 1999 Jun; 156(6):876-84. PubMed ID: 10360126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparative study of the pharmacological properties of sultopride sulpiride and other antipsychotic drugs: influence of sultopride, sulpiride and other antipsychotic drugs on spontaneous locomotor activity and changes in locomotor activity induced by apomorphine and clonidine in mice].
    Horikomi K; Fujita M
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):339-52. PubMed ID: 2880435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy.
    Kapur S; Cho R; Jones C; McKay G; Zipursky RB
    Biol Psychiatry; 1999 May; 45(9):1217-20. PubMed ID: 10331115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine D2 occupancy as a biomarker for antipsychotics: quantifying the relationship with efficacy and extrapyramidal symptoms.
    de Greef R; Maloney A; Olsson-Gisleskog P; Schoemaker J; Panagides J
    AAPS J; 2011 Mar; 13(1):121-30. PubMed ID: 21184291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Central 5-HT2A and D2 dopamine receptor occupancy after sublingual administration of ORG 5222 in healthy men.
    Andrée B; Halldin C; Vrijmoed-de Vries M; Farde L
    Psychopharmacology (Berl); 1997 Jun; 131(4):339-45. PubMed ID: 9226735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The next generation of "atypical" antipsychotics: the role of positron emission tomography].
    Gründer G; Wong DF
    Fortschr Neurol Psychiatr; 2003 Aug; 71(8):415-20. PubMed ID: 12910447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.
    Talbot PS; Laruelle M
    Eur Neuropsychopharmacol; 2002 Dec; 12(6):503-11. PubMed ID: 12468013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine D2 receptor occupancy and clinical effects: a systematic review and pooled analysis.
    Uchida H; Takeuchi H; Graff-Guerrero A; Suzuki T; Watanabe K; Mamo DC
    J Clin Psychopharmacol; 2011 Aug; 31(4):497-502. PubMed ID: 21694629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.